MRVI
Maravai·NASDAQ
--
--(--)
--
--(--)
MRVI fundamentals
Maravai (MRVI) Revenue Breakdown: Q4 2025 Business & Regional Performance
Maravai (MRVI) reported total revenue of 49.87M USD in Q4 2025, with its core business segment Nucleic Acid Production contributing 69.38%. Regionally, Nucleic Acid Production remained the largest market, accounting for 60.90% of total revenue. Explore Maravai's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Maravai (MRVI) reported total revenue of 49.87M USD in Q4 2025, with its core business segment Nucleic Acid Production contributing 69.38%. Regionally, Nucleic Acid Production remained the largest market, accounting for 60.90% of total revenue. Explore Maravai's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did Maravai beat or miss consensus estimates last quarter?What factors drove the changes in Maravai's revenue and profit?What is Maravai's gross profit margin?What were the key takeaways from Maravai's earnings call?What does Maravai do and what are its main business segments?What is Maravai's latest dividend and current dividend yield?What guidance did Maravai's management provide for the next earnings period?What is the revenue and EPS growth rate for Maravai year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
